Cargando…

Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use

BACKGROUND: Take-home naloxone (THN) programmes are an evidence-based opioid overdose prevention initiative. Elevated opioid overdose risk following prison release means release from custody provides an ideal opportunity for THN initiatives. However, whether Australian prisoners would utilise such p...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtis, Michael, Dietze, Paul, Aitken, Campbell, Kirwan, Amy, Kinner, Stuart A., Butler, Tony, Stoové, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497216/
https://www.ncbi.nlm.nih.gov/pubmed/30241532
http://dx.doi.org/10.1186/s12954-018-0255-5
_version_ 1783415427970367488
author Curtis, Michael
Dietze, Paul
Aitken, Campbell
Kirwan, Amy
Kinner, Stuart A.
Butler, Tony
Stoové, Mark
author_facet Curtis, Michael
Dietze, Paul
Aitken, Campbell
Kirwan, Amy
Kinner, Stuart A.
Butler, Tony
Stoové, Mark
author_sort Curtis, Michael
collection PubMed
description BACKGROUND: Take-home naloxone (THN) programmes are an evidence-based opioid overdose prevention initiative. Elevated opioid overdose risk following prison release means release from custody provides an ideal opportunity for THN initiatives. However, whether Australian prisoners would utilise such programmes is unknown. We examined the acceptability of THN in a cohort of male prisoners with histories of regular injecting drug use (IDU) in Victoria, Australia. METHODS: The sample comprised 380 men from the Prison and Transition Health (PATH) Cohort Study; all of whom reported regular IDU in the 6 months prior to incarceration. We asked four questions regarding THN during the pre-release baseline interview, including whether participants would be willing to participate in prison-based THN. We describe responses to these questions along with relationships between before- and during-incarceration factors and willingness to participate in THN training prior to release from prison. RESULTS: Most participants (81%) reported willingness to undertake THN training prior to release. Most were willing to resuscitate a friend using THN if they were trained (94%) and to be revived by a trained peer (91%) using THN. More than 10 years since first injection (adjusted odds ratio [AOR] 2.22, 95%CI 1.03–4.77), having witnessed an opioid overdose in the last 5 years (AOR 2.53, 95%CI 1.32–4.82), having ever received alcohol or other drug treatment in prison (AOR 2.41, 95%CI 1.14–5.07) and injecting drugs during the current prison sentence (AOR 4.45, 95%CI 1.73–11.43) were significantly associated with increased odds of willingness to participate in a prison THN programme. Not specifying whether they had injected during their prison sentence (AOR 0.37, 95%CI 0.18–0.77) was associated with decreased odds of willingness to participate in a prison THN training. CONCLUSION: Our findings suggest that male prisoners in Victoria with a history of regular IDU are overwhelmingly willing to participate in THN training prior to release. Factors associated with willingness to participate in prison THN programmes offer insights to help support the implementation and uptake of THN programmes to reduce opioid-overdose deaths in the post-release period.
format Online
Article
Text
id pubmed-6497216
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64972162019-05-06 Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use Curtis, Michael Dietze, Paul Aitken, Campbell Kirwan, Amy Kinner, Stuart A. Butler, Tony Stoové, Mark Harm Reduct J Research BACKGROUND: Take-home naloxone (THN) programmes are an evidence-based opioid overdose prevention initiative. Elevated opioid overdose risk following prison release means release from custody provides an ideal opportunity for THN initiatives. However, whether Australian prisoners would utilise such programmes is unknown. We examined the acceptability of THN in a cohort of male prisoners with histories of regular injecting drug use (IDU) in Victoria, Australia. METHODS: The sample comprised 380 men from the Prison and Transition Health (PATH) Cohort Study; all of whom reported regular IDU in the 6 months prior to incarceration. We asked four questions regarding THN during the pre-release baseline interview, including whether participants would be willing to participate in prison-based THN. We describe responses to these questions along with relationships between before- and during-incarceration factors and willingness to participate in THN training prior to release from prison. RESULTS: Most participants (81%) reported willingness to undertake THN training prior to release. Most were willing to resuscitate a friend using THN if they were trained (94%) and to be revived by a trained peer (91%) using THN. More than 10 years since first injection (adjusted odds ratio [AOR] 2.22, 95%CI 1.03–4.77), having witnessed an opioid overdose in the last 5 years (AOR 2.53, 95%CI 1.32–4.82), having ever received alcohol or other drug treatment in prison (AOR 2.41, 95%CI 1.14–5.07) and injecting drugs during the current prison sentence (AOR 4.45, 95%CI 1.73–11.43) were significantly associated with increased odds of willingness to participate in a prison THN programme. Not specifying whether they had injected during their prison sentence (AOR 0.37, 95%CI 0.18–0.77) was associated with decreased odds of willingness to participate in a prison THN training. CONCLUSION: Our findings suggest that male prisoners in Victoria with a history of regular IDU are overwhelmingly willing to participate in THN training prior to release. Factors associated with willingness to participate in prison THN programmes offer insights to help support the implementation and uptake of THN programmes to reduce opioid-overdose deaths in the post-release period. BioMed Central 2018-09-21 /pmc/articles/PMC6497216/ /pubmed/30241532 http://dx.doi.org/10.1186/s12954-018-0255-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Curtis, Michael
Dietze, Paul
Aitken, Campbell
Kirwan, Amy
Kinner, Stuart A.
Butler, Tony
Stoové, Mark
Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use
title Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use
title_full Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use
title_fullStr Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use
title_full_unstemmed Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use
title_short Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use
title_sort acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497216/
https://www.ncbi.nlm.nih.gov/pubmed/30241532
http://dx.doi.org/10.1186/s12954-018-0255-5
work_keys_str_mv AT curtismichael acceptabilityofprisonbasedtakehomenaloxoneprogrammesamongacohortofincarceratedmenwithahistoryofregularinjectingdruguse
AT dietzepaul acceptabilityofprisonbasedtakehomenaloxoneprogrammesamongacohortofincarceratedmenwithahistoryofregularinjectingdruguse
AT aitkencampbell acceptabilityofprisonbasedtakehomenaloxoneprogrammesamongacohortofincarceratedmenwithahistoryofregularinjectingdruguse
AT kirwanamy acceptabilityofprisonbasedtakehomenaloxoneprogrammesamongacohortofincarceratedmenwithahistoryofregularinjectingdruguse
AT kinnerstuarta acceptabilityofprisonbasedtakehomenaloxoneprogrammesamongacohortofincarceratedmenwithahistoryofregularinjectingdruguse
AT butlertony acceptabilityofprisonbasedtakehomenaloxoneprogrammesamongacohortofincarceratedmenwithahistoryofregularinjectingdruguse
AT stoovemark acceptabilityofprisonbasedtakehomenaloxoneprogrammesamongacohortofincarceratedmenwithahistoryofregularinjectingdruguse